Physician profile
Alexandre K Wang
NPI 1366949703
$3,213.68
in general payments reported to CMS, 2019-2025
11 companies · $3,083 in 2025
The $3,083 reported for 2025 was more than what 86% of Surgery providers received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $131 · 2025: $3,083.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,954 · Food and Beverage: $1,260.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,954.08 |
| Food and Beverage | $1,259.60 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| W. L. Gore & Associates, INC. | $1,932.13 | 2025 | Gore Synecor Biomaterial, Gore Synecor Preperitoneal Biomaterial |
| Intuitive Surgical, INC. | $963.65 | 2025 | |
| Ethicon US, LLC | $114.22 | 2024 | Harmonic, Vistaseal |
| Atricure, INC. | $58.47 | 2025 | Atricure Cryoice Cryosphere Cryoablation System |
| Pacira Pharmaceuticals Incorporated | $33.10 | 2024-2025 | Exparel |
| Cvrx, INC. | $26.69 | 2025 | Barostim Neo System |
| Stryker Corporation | $20.23 | 2025 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Takeda Pharmaceuticals U.S.A., INC. | $20.04 | 2025 | Hyqvia |
| Boston Scientific Corporation | $16.16 | 2025 | Eluvia |
| Kerecis Limited | $15.49 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
| Lemaitre Vascular, INC. | $13.50 | 2025 | Artegraft Vascular Graft |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alexandre Wang listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.